Microbiome Therapeutics and Preclinical Models

Preclinical models have been a point of contention within the microbiome space, with many believing the current models are not fit for purpose due to the microenvironment of the models not being comparable to that of humans. Hence recent research has revolved around finding more appropriate animal models to replicate how human diseases interact with the microbiota.

This 3-page infographic explores the current data surrounding preclinical models, looking at efficacy, toxicity and pharmacokinetic models, and takes a look towards the future.

Microbiome Therapeutic Preclinical Models Infographic

Here are just some of the key highlights covered in the infographic.

  • Overview of the difficulties with preclinical models
  • Analysis of efficacy, toxicity and safety and pharmacokinetic models
  • What the future holds for preclinical models

You May Also Be Interested In…

What is Beacon?

Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.

Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.

This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.

We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!

Request Demonstration

Menu
Search Icon
Close Icon
Search